Building on this, in 2018 the launch of the NHS GMS created a step change in the use of genomics in the NHS. It is ten years since the ground-breaking 100,000 Genomes Project was announced to sequence 100,000 whole genomes of patients in the NHS to support clinical care and to drive research. The NHS has a long history of genomics dating back to the first genetic laboratory services in the 1960s. Genomic medicine has the potential to offer a greater understanding of how our genetic makeup impacts on our health and to change the way disease is managed and treated. Genomics is the study of a person’s DNA, their genes and how they are expressed and interact to influence the growth, development and the working of the body. Professor Dame Sue Hill DBE FMedSci FRSB FRCP (Hon) FRCPath (Hon)Ĭhief Scientific Officer for England and Senior Responsible Officer for Genomics in the NHS Executive summary This first ever NHS genomics strategy signals the next big step in healthcare in the NHS and the journey to realise the potential of genomics for our patients, our communities and the population we serve. Evolving the service through cutting-edge science, research and innovation to ensure that patients can benefit from rapid implementation of advances.Enabling genomics to be at the forefront of the data and digital revolution, ensuring genomic data can be interpreted and informed by other diagnostic and clinical data.Delivering equitable genomic testing for improved outcomes in cancer, rare, inherited and common diseases and in enabling precision medicine and reducing adverse drug reactions.Embedding genomics across the NHS, through a world leading innovative service model from primary and community care through to specialist and tertiary care.This strategy sets out four priority areas to this approach: Over the next five years, the NHS will push the boundaries to improve care and treatment options for our patients, developing shared clinical and access standards, data platforms and governance, and an interoperable informatics infrastructure.Īs we bring the benefits of genomics to patients and our population, we need a comprehensive and ambitious national approach covering prevention, diagnosis and targeted treatments that enables patients, families and carers to participate in shared decision making. That work is now being taken forward through the NHS Genomic Medicine Service (GMS) – a world leading genomic healthcare service, delivering cutting-edge benefits for patients in the NHS.Īs a national integrated healthcare system, the NHS is in a unique position to continue to lead the world in implementing genomic medicine, operating as a nationally coordinated, locally delivered network. The investment made by the UK government and the NHS in genomics over the last decade, including through the ground breaking 100,000 Genomes Project delivered by the NHS and Genomics England alongside the existing genomics expertise within the NHS, laid the foundations for the use of genomics in routine clinical care. Genomics will be at the heart of this future and the next generation of healthcare in the NHS. The solutions are unlikely to be found in the usual places and ambition is required to think about the future as well as the immediate short-term, to continue to deliver a sustainable model of healthcare for patients in England. The immediate focus of the NHS is on tackling the inevitable COVID backlogs and meeting new care demands, within the budget set by government and Parliament.Īs the NHS does this, it will need to think differently about the way healthcare is delivered. The impact of the COVID-19 pandemic on services, staff and patients are still being felt across the country. The last two years have been the most challenging in the history of the NHS. Publication reference: PR1627 A strategy for embedding genomics in the NHS over the next 5 years.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |